This role has primary responsibility for medical monitoring of ophthalmology trials; scientific and clinical oversight of safety and efficacy data; and cross-functional strategic input supporting protocol design, feasibility assessment, regulatory and medical strategy, and engagement with external ophthalmology experts. Provides real-time safety and medical input, including evaluation of adverse events, serious adverse events (SAEs), protocol-defined ophthalmic safety events (e.g., intraocular inflammation, endophthalmitis, retinal tears/detachments, IOP changes), and deviations.